Literature DB >> 6865941

Growth regulation of melanoma cells by interferon and (2'-5')oligoadenylate synthetase.

A A Creasey, D A Eppstein, Y V Marsh, Z Khan, T C Merigan.   

Abstract

We report that endogenous, as well as exogenous, interferon (IFN) regulates the growth of human melanoma cells in culture. When antibodies directed against human fibroblast IFN were incorporated into the media of high-density cells stimulated to proliferate with serum, the cells entered the cell cycle earlier than did the controls. In investigating the biochemical basis for this finding, we have found that there is an inverse relationship between the (2'-5')oligoadenylate synthetase levels and the percentage of cells in S in untreated cultures. Upon IFN treatment, the relationship is obliterated and (2'-5')oligoadenylate synthetase levels increase throughout all phases of the cell cycle. This increase in enzyme levels correlates well with the decreased probability of the IFN-treated cells to cycle. These findings suggest a biological role for IFN as a negative growth factor for cells in culture.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6865941      PMCID: PMC368600          DOI: 10.1128/mcb.3.5.780-786.1983

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  Synthesis of an oligonucleotide inhibitor of protein synthesis in rabbit reticulocyte lysates analogous to that formed in extracts from interferon-treated cells.

Authors:  A G Hovanessian; I M Kerr
Journal:  Eur J Biochem       Date:  1978-03

2.  Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A.

Authors:  C Baglioni; M A Minks; P A Maroney
Journal:  Nature       Date:  1978-06-22       Impact factor: 49.962

3.  Mechanism of interferon action. Properties of an interferon-mediated ribonucleolytic activity from mouse L929 cells.

Authors:  D A Eppstein; C E Samuel
Journal:  Virology       Date:  1978-08       Impact factor: 3.616

4.  pppA2'p5'A2'p5'A: an inhibitor of protein synthesis synthesized with an enzyme fraction from interferon-treated cells.

Authors:  I M Kerr; R E Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

5.  2-5A synthetase: assay, distribution and variation with growth or hormone status.

Authors:  G R Stark; W J Dower; R T Schimke; R E Brown; I M Kerr
Journal:  Nature       Date:  1979-03-29       Impact factor: 49.962

6.  On the varied biologic effects of interferon.

Authors:  I Gresser
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

7.  Accumulation of an mRNA and protein in interferon-treated Ehrlich ascites tumour cells.

Authors:  P J Farrell; R J Broeze; P Lengyel
Journal:  Nature       Date:  1979-06-07       Impact factor: 49.962

8.  Interferon, double-stranded RNA and RNA degradation. Fractionation of the endonucleaseINT system into two macromolecular components; role of a small molecule in nuclease activation.

Authors:  L Ratner; R C Wiegand; P J Farrell; G C Sen; B Cabrer; P Lengyel
Journal:  Biochem Biophys Res Commun       Date:  1978-04-14       Impact factor: 3.575

9.  Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA.

Authors:  P J Farrell; G C Sen; M F Dubois; L Ratner; E Slattery; P Lengyel
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

10.  Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: a novel oligonucleotide synthesized by interferon-treated L cell extracts.

Authors:  M J Clemens; B R Williams
Journal:  Cell       Date:  1978-03       Impact factor: 41.582

View more
  11 in total

Review 1.  Regulation of cell proliferation and differentiation by interferons.

Authors:  M J Clemens; M A McNurlan
Journal:  Biochem J       Date:  1985-03-01       Impact factor: 3.857

2.  Effect of interferon on Vero cells persistently infected with Sendai virus compared to Vero cells persistently infected with SSPE virus.

Authors:  M Crespi; M N Chiu; J K Struthers; B D Schoub; S F Lyons
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Activation of 2',5'-oligoadenylate synthetase activity on induction of HL-60 leukemia cell differentiation.

Authors:  E L Schwartz; L A Nilson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

4.  Induced expression of the endogenous beta interferon gene in adenovirus type 5-transformed rat fibroblasts.

Authors:  U Nielsch; R Pine; S G Zimmer; L E Babiss
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells.

Authors:  Yogita Ghodke-Puranik; Jessica M Dorschner; Danielle M Vsetecka; Shreyasee Amin; Ashima Makol; Floranne Ernste; Thomas Osborn; Kevin Moder; Vaidehi Chowdhary; Elias Eliopoulos; Maria I Zervou; George N Goulielmos; Mark A Jensen; Timothy B Niewold
Journal:  Arthritis Rheumatol       Date:  2017-11-09       Impact factor: 10.995

Review 6.  Regulation of the interferon system and cell growth by the IRF transcription factors.

Authors:  T Taniguchi; H Harada; M Lamphier
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.

Authors:  P Benech; Y Mory; M Revel; J Chebath
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

8.  Long-term pegylated interferon-alpha and its potential in the treatment of melanoma.

Authors:  Reinhard Dummer; Joanna Mangana
Journal:  Biologics       Date:  2009-07-13

9.  Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells.

Authors:  A Yarden; H Shure-Gottlieb; J Chebath; M Revel; A Kimchi
Journal:  EMBO J       Date:  1984-05       Impact factor: 11.598

10.  Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better.

Authors:  Heni Rachmawati; Adhitya Jessica; Yeyet Cahyati Sumirtaputra; Debbie Sofie Retnoningrum; Amirah Adlia; Ratih Asmana Ningrum
Journal:  Sci Pharm       Date:  2016-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.